Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „infliximab“
Suchtreffer
Begriffe & Kennungen
Remsima · 4.5 · It is recommended that live vaccines not be given concurrently with infliximab. It is also recommended that li
Eintrag öffnenRemsima · 4.5 · It is recommended that therapeutic infectious agents not be given concurrently with infliximab (see section 4.
Eintrag öffnenRemsima · 4.5 · It is recommended that therapeutic infectious agents not be given concurrently with infliximab (see section 4.
Eintrag öffnenRemsima · 4.5 · It is recommended that therapeutic infectious agents not be given concurrently with infliximab (see section 4.
Eintrag öffnenRemsima · 4.5 · The combination of infliximab with other biological therapeutics used to treat the same conditions as inflixim
Eintrag öffnenRemsima · 4.5 · The combination of infliximab with other biological therapeutics used to treat the same conditions as inflixim
Eintrag öffnenRemsima · 4.5 · The combination of infliximab with other biological therapeutics used to treat the same conditions as inflixim
Eintrag öffnenRemsima · 4.8 · 18 Infusion reactions following re-administration of infliximab
Eintrag öffnenRemsima · 4.8 · 19 In clinical studies 36% of infliximab-treated patients were treated for infections compared with 25% of pla
Eintrag öffnenRemsima · 4.8 · 56 In a 1-year clinical study with repeated infusions of IV infliximab in patients with Crohn's disease (ACCEN
Eintrag öffnenRemsima · 4.8 · 95 There are insufficient data on the incidence of delayed hypersensitivity reactions after infliximab-free in
Eintrag öffnenRemsima · 4.8 · Approximately half of infliximab-treated patients in clinical studies who were ANA negative at baseline develo
Eintrag öffnenRemsima · 4.8 · Approximately half of infliximab-treated patients in clinical studies who were ANA negative at baseline develo
Eintrag öffnenRemsima · 4.8 · Approximately half of infliximab-treated patients in clinical studies who were ANA negative at baseline develo
Eintrag öffnenRemsima · 4.8 · Because immunogenicity analyses are assay-specific, comparison of the incidence of antibodies to infliximab re
Eintrag öffnenRemsima · 4.8 · Immunogenicity Antibodies to infliximab developed in 38% of patients receiving 3 mg/kg compared with 12% of pa
Eintrag öffnenRemsima · 4.8 · Immunogenicity Antibodies to infliximab developed in 38% of patients receiving 3 mg/kg compared with 12% of pa
Eintrag öffnenRemsima · 4.8 · Immunogenicity Antibodies to infliximab were detected in 3 (2.9%) paediatric patients.
Eintrag öffnenRemsima · 4.8 · Immunogenicity Antibodies to infliximab were detected in 3 (2.9%) paediatric patients.
Eintrag öffnenRemsima · 4.8 · Immunogenicity Antibodies to infliximab were detected in 4 (7.7%) patients through week 54.
Eintrag öffnen